nytimes.com / .nytimes-com-health / Page 6

Though the Sackler name was tarnished over Purdue Pharma's role in the opioid crisis, Arthur Sackler's should not be, she insisted; a company founder, he died well before the trouble began.

U.S. and state officials say the consolidation of the public health agency's vast trove of information could expose patients and will delay analysis of long-term trends.

A federal investigation found a Kentucky nonprofit pushed hospital workers toward surgery despite signs of revival in patients.

The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill's safety.

Screening can now determine their risk for an ever-growing list of conditions -- including ones we can't do much about.

The U.S. health secretary said people should have access to experimental therapies including unregulated stem cells. But some methods have resulted in blindness, tumors and other injuries.

As Republicans weigh steep cuts to the program, Times reporters want to hear from people who rely on the Affordable Care Act for coverage.

Screening can now determine their risk for an ever-growing list of conditions -- including ones we can't do much about.

The spending proposal terminates support of health programs that, according to the proposal, "do not make Americans safer."

At issue is a how to interpret a federal law barring hospitals from turning away poor or uninsured patients.